Dr. George F. Van de Woude 1935–2021

A pioneering Dutch-American cancer researcher, Dr. George F. Vande Woude was internationally recognized for his discovery of the MET oncogene, a landmark breakthrough that advanced the world’s understanding of how cancer spreads and grows. Over his distinguished career, he served as Founding Director of Research at the Van Andel Institute (VAI) in Grand Rapids, Michigan, and as Director of the Basic Research Program at the National Cancer Institute (NCI) in Frederick, Maryland.

Elected to the National Academy of Sciences, Dr. Vande Woude was widely regarded as a visionary in molecular oncology whose discoveries helped transform cancer research and treatment. He also served on advisory boards at Memorial Sloan Kettering Cancer Center, Johns Hopkins University, and other leading institutions. A mentor to generations of scientists, his legacy continues through the MET research field and the countless lives impacted by his work.

 

---